SAM
SGMO

Shell Asset Management’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Shell Asset Management’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-42,138
Closed -$174K – 1403
2022
Q2 		$174K Buy
42,138
+73
+0.2% +$316 0.01% 1154
2022
Q1 		$244K Sell
42,065
-6,230
-13% -$37K 0.01% 1117
2021
Q4 		$362K Buy
48,295
+12,655
+36% +$110K 0.01% 1039
2021
Q3 		$321K Sell
35,640
-1,530
-4% -$15.1K 0.01% 1061
2021
Q2 		$445K Buy
37,170
+2,010
+6% +$22.8K 0.01% 970
2021
Q1 		$441K Buy
+35,160
New +$474K 0.01% 910

Other funds holding SGMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
RCMU
Rokos Capital Management (UK) London, United Kingdom $13.2B AUM 85.71% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Shell Asset Management's SGMO Position: Q3 2022 in Review

Shell Asset Management sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q3 2022, closing a stake of 42,138 shares — an estimated $174K sold.

Shell Asset Management first reported a position in SGMO in Q1 2021 and held it in 6 quarters. The position peaked at $445K in Q2 2021. 197 funds tracked by Wall St. Rank hold SGMO as of Q3 2022.

  • Shell Asset Management reported no remaining SANGAMO THERAPEUTICS INC position as of Q3 2022 after selling out during the quarter.
  • Shell Asset Management sold 42,138 SANGAMO THERAPEUTICS INC shares in Q3 2022, an estimated $174K.
  • Shell Asset Management first reported a position in SANGAMO THERAPEUTICS INC in Q1 2021 and held it in 6 quarters.
  • Shell Asset Management's SANGAMO THERAPEUTICS INC position peaked at $445K in Q2 2021.
  • 197 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q3 2022.

Based on Shell Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.